MPR_2025v15n4

Medicinal Plant Research 2025, Vol.15, No.4, 169-177 http://hortherbpublisher.com/index.php/mpr 177 Zhao C., Qu Q., Yang F., Li Z., Yang P., Han L., and Shi X., 2021, Monascus ruber fermented Panax ginseng ameliorates lipid metabolism disorders and modulates gut microbiota in rats fed a high-fat diet, Journal of Ethnopharmacology, 278: 114300. https://doi.org/10.1016/j.jep.2021.114300 Zhao L., Sui M., Zhang T., and Zhang K., 2023, The interaction between ginseng and gut microbiota, Frontiers in Nutrition, 10: 1301468. https://doi.org/10.3389/fnut.2023.1301468 Zhou Q., Yang C., Jia M., Qu Q., Peng X., Ren W., Li G., Xie Y., Li B., and Shi X., 2025, Gut microbiota-targeted intervention of hyperlipidemia using Monascus-fermented ginseng, Pharmaceuticals, 18(5): 661. https://doi.org/10.3390/ph18050661 Zhou R., He D., Xie J., Zhou Q., Zeng H., Li H., and Huang L., 2021, The synergistic effects of polysaccharides and ginsenosides from American ginseng (Panax quinquefolius L.) ameliorating cyclophosphamide-induced intestinal immune disorders and gut barrier dysfunctions based on microbiome-metabolomics analysis, Frontiers in Immunology, 12: 665901. https://doi.org/10.3389/fimmu.2021.665901

RkJQdWJsaXNoZXIy MjQ4ODYzNA==